Event Brief
Nov 10, 2025 at 11:03 PM ET
NeuroScientific expands bowel disease stem cell therapy
By The BriefBrief
NeuroScientific Biopharmaceuticals has dosed a fourth Crohn’s patient with its StemSmart therapy ahead of phase 2 trials.
WHO: NeuroScientific Biopharmaceuticals
WHAT: Dosed a fourth Crohn’s patient with StemSmart therapy
WHEN: Nov 10, 2025 at 7:00 PM ET
WHERE: Not specified
WHY: To advance phase 2 trials for a novel treatment
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21414 of 21414
Same format. Every time.
Continue reading — sign in or create a free account with
